Peptide mimics of monocyte chemoattractant protein-1 (MCP-1) with an antagonistic activity

被引:11
作者
Kaji, M
Ikari, M
Hashiguchi, S
Ito, Y
Matsumoto, R
Yoshimura, T
Kuratsu, J
Sugimura, K
机构
[1] Kagoshima Univ, Fac Engn, Dept Bioengn, Kagoshima 8900065, Japan
[2] Kagoshima Univ, Fac Med, Dept Neurosurg, Kagoshima 8908544, Japan
[3] NCI, Immunobiol Lab, Immunopathol Sect, Frederick, MD 21701 USA
关键词
inhibition; MCP-1; molecular design; peptide mimic; phage library;
D O I
10.1093/oxfordjournals.jbchem.a002893
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we attempted to analyze the peptide motifs recognized by 24822.111 and F9, monoclonal antibodies (mAbs) that inhibit the chemotactic activity of monocyte chemoattractant protein-1 (MCP-1), a member of the CC subfamily of chemokines, We isolated phage clones from a phage display library and identified six peptide motifs, One of these clones, C27, was strongly and specifically recognized by 24822.111 mAb, while another, G25, was similarly recognized by F9 mAb, Both the C27 motif and the G25 motif contain two cysteines in their sequences and have little homology to the primary amino acid sequence of MCP-1, These clones, however, bound to THP-1 cells, and the binding was: competitively inhibited by MCP-1, The clones strongly inhibited the MCP-1-induced chemotaxis of human monocytes, The synthetic and intramolecularly disulfide-linked peptides of C27 and G25 (sC27 and sG25) also inhibited the chemotaxis induced by MCP-1, while their derivatives with serine in place of cysteine did not, suggesting the importance of the loop structure for the inhibition. These results suggest that sC27 and sG25 may mimic the MCP-1-binding domain to the MCP-1 receptor.
引用
收藏
页码:577 / 583
页数:7
相关论文
共 25 条
[1]   Site-directed mutagenesis of monocyte chemoattractant protein-1 identifies two regions of the polypeptide essential for biological activity [J].
Beall, CJ ;
Mahajan, S ;
Kuhn, DE ;
Kolattukudy, PE .
BIOCHEMICAL JOURNAL, 1996, 313 :633-640
[2]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[3]  
Fukumoto T, 1998, J IMMUNOL, V161, P6622
[4]   Peptide mimics of the CTLA4-binding domain stimulate T-cell proliferation [J].
Fukumoto, T ;
Torigoe, N ;
Kawabata, S ;
Murakami, M ;
Uede, T ;
Nishi, T ;
Ito, Y ;
Sugimura, K .
NATURE BIOTECHNOLOGY, 1998, 16 (03) :267-270
[5]   ANTAGONISTS OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 IDENTIFIED BY MODIFICATION OF FUNCTIONALLY CRITICAL NH2-TERMINAL RESIDUES [J].
GONG, JH ;
CLARKLEWIS, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :631-640
[6]   Heteronuclear (H-1, C-13, N-15) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer [J].
Handel, TM ;
Domaille, PJ .
BIOCHEMISTRY, 1996, 35 (21) :6569-6584
[7]   MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) IN INFLAMMATORY JOINT DISEASES AND ITS INVOLVEMENT IN THE CYTOKINE NETWORK OF RHEUMATOID SYNOVIUM [J].
HARIGAI, M ;
HARA, M ;
YOSHIMURA, T ;
LEONARD, EJ ;
INOUE, K ;
KASHIWAZAKI, S .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 69 (01) :83-91
[8]   PRODUCTION AND CHARACTERIZATION OF HUMAN GLIOMA CELL-DERIVED MONOCYTE CHEMOTACTIC FACTOR [J].
KURATSU, J ;
LEONARD, EJ ;
YOSHIMURA, T .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (05) :347-351
[9]   Chemokines - Chemotactic cytokines that mediate inflammation [J].
Luster, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :436-445
[10]   Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1α-binding activity [J].
Meta, A ;
Torigoe, N ;
Ito, Y ;
Arakaki, R ;
Nakashima, H ;
Sugimura, K .
MOLECULAR IMMUNOLOGY, 1999, 36 (18) :1249-1254